[HTML][HTML] Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

B Goel, AK Tiwari, RK Pandey, AP Singh, S Kumar… - Translational …, 2022 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin
cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) …

Cancer stem cells in head and neck squamous cell carcinoma: identification, characterization and clinical implications

C Peitzsch, J Nathansen, SI Schniewind, F Schwarz… - Cancers, 2019 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed
cancer worldwide. Despite advances in the treatment management, locally advanced …

Rethink of EGFR in cancer with its kinase independent function on board

R Thomas, Z Weihua - Frontiers in oncology, 2019 - frontiersin.org
The epidermal growth factor receptor (EGFR) is one of most potent oncogenes that are
commonly altered in cancers. As a receptor tyrosine kinase, EGFR's kinase activity has been …

[HTML][HTML] Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

N Tanaka, AA Osman, Y Takahashi, A Lindemann… - Oral oncology, 2018 - Elsevier
Objectives Currently there are no standard biomarkers of head and neck squamous cell
carcinoma (HNSCC) response to therapy. This is, due to a lack of adequate predictive tumor …

IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling

VK Pidugu, MM Wu, AH Yen, HB Pidugu, KW Chang… - Oncogene, 2019 - nature.com
IFIT1 and IFIT3 are abundant products of interferon-stimulating genes. While the importance
of IFIT1 and IFIT3 in the prognosis of cancer has been reported, the molecular basis of IFIT1 …

The story of EGFR: from signaling pathways to a potent anticancer target

S Ramani, S Samant, SM Manohar - Future Medicinal Chemistry, 2022 - Taylor & Francis
EGFR is a member of the ERBB family. It plays a significant role in cellular processes such
as growth, survival and differentiation via the activation of various signaling pathways. EGFR …

Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers

RS Cheung, T Taniguchi - International journal of hematology, 2017 - Springer
Fanconi anemia (FA), the most common form of inherited bone marrow failure, predisposes
to leukemia and solid tumors. FA is caused by the genetic disruption of a cellular pathway …

Dual-color bioluminescent sensor proteins for therapeutic drug monitoring of antitumor antibodies

M van Rosmalen, Y Ni, DFM Vervoort, R Arts… - Analytical …, 2018 - ACS Publications
Monitoring the levels of therapeutic antibodies in individual patients would allow patient-
specific dose optimization, with the potential for major therapeutic and financial benefits. Our …

Nimotuzumab for patients with inoperable cancer of the head and neck

T Crombet Ramos, B Mestre Fernández… - Frontiers in …, 2020 - frontiersin.org
EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and
metastasis of the cancer cells. Nimotuzumab is an engineered, intermediate affinity anti …

Precision therapy of head and neck squamous cell carcinoma

PJ Polverini, NJ D'silva, YL Lei - Journal of dental research, 2018 - journals.sagepub.com
Precision medicine is an approach to disease prevention and treatment that takes into
account genetic variability and environmental and lifestyle influences that are unique to …